Replimune (REPL) Shares Outstanding (2017 - 2026)

Replimune has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $82.7 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 7.31% year-over-year to $82.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.7 million (up 7.31% YoY) and the FY2026 annual result came in at $82.7 million, up 7.31% from the prior year.
• Shares Outstanding (Entity) rose to $82.7 million in Q1 2026 per REPL's latest filing, from $79.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $82.7 million in Q1 2026 and troughed at $47.3 million in Q1 2022.
• A 5-year average of $65.3 million and a median of $61.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) rose 1.66% in 2022, then rose 25.51% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $56.6 million in 2022, then climbed by 8.4% to $61.4 million in 2023, then increased by 25.45% to $77.0 million in 2024, then grew by 3.4% to $79.6 million in 2025, then climbed by 3.88% to $82.7 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $82.7 million, $79.6 million, and $78.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.